Alain Van Gool,
Head of Biomarkers in Personalised Healthcare
Alain van Gool specializes in translational biomarkers in pharmaceutical drug development, with particular interest in applications in personalized healthcare. His professional background is a mix of academia (1991-1998; ErasmusMC, Cancer UK; 2009-now, Radboud University Nijmegen), pharmaceutical industry (1999-2011; Organon, Schering-Plough, MSD), applied research institute (2011-now; TNO), and university medical center (2011-now; Radboudumc). He has lead technology-based laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of disease areas. While working in Europe, USA and Asia, he and his teams contributed to over 150 projects in various phases of biomarker R&D. His technical expertise resides most strongly in molecular profiling technologies (genetics, genomics, proteomics, metabolomics, bioinformatics) and their applications in scientific research. His current positions are Head of biomarkers in personalized healthcare at TNO, Head of the Radboud center for proteomics, glycomics and metabolomics, and Coordinator of Radboudumc Technology Centers of the Radboud University Medical Center, and professor Molecular Profiling at the Radboud University Nijmegen (Netherlands). He serves on scientific advisory boards of several organisations and has been a frequently invited thought leader and speaker at translational medicine events.
|
|
